Clinical Trials Browser

Phase 1/2 × Has results × dactolisib × Clear all

NCT01717898 2018-03-27

A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Phase 1/2 Terminated

6 enrolled 5 charts

Castrate-resistant Prostate Cancer

NCT01453595 2016-02-29

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Phase 1/2 Terminated

10 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms